News
Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire ...
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...
1don MSN
Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...
In the latest episode of Inside Forbes India Podcast, Naini Thaker discusses her deep-dive profile on Dilip Shanghvi, the low ...
Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...
Insider Monkey on MSN13d
West Pharmaceutical Services, Inc. (WST): One of the Low Profile Dividend Champions to BuyIn this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) stands against other low ...
Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results